2024 Regular Session • New Hampshire Legislature
HB172
Legislative Summary
Relative to investigating potential redundancies between the prescription drug affordability board and existing state agency programs regarding prescription drug cost data.
Bill History
1/3/2023
Introduced 01/04/2023 and referred to Commerce and Consumer Affairs
House of Representatives
1/19/2023
Public Hearing: 01/26/2023 10:00 am Legislative Office Building 302-304
House of Representatives
2/1/2023
Subcommittee Work Session: 02/08/2023 10:45 am Legislative Office Building 302-304
House of Representatives
2/23/2023
Subcommittee Work Session: 03/08/2023 10:00 am Legislative Office Building 302-304
House of Representatives
2/23/2023
Executive Session: 03/08/2023 01:15 pm Legislative Office Building 302-304
House of Representatives
3/13/2023
Retained in Committee
House of Representatives
8/30/2023
==CANCELLED== Subcommittee Work Session: 09/06/2023 01:15 pm Legislative Office Building 302-304
House of Representatives
9/6/2023
==RESCHEDULED== Subcommittee Work Session: 09/20/2023 01:15 pm Legislative Office Building 302-304 House Calendar 36
House of Representatives
10/17/2023
==RECESSED== Executive Session: 11/08/2023 01:30 pm Legislative Office Building 302-304 House Calendar 42
House of Representatives
11/8/2023
==CANCELLED== Executive Session: 11/15/2023 11:00 am Legislative Office Building 302-304 House Calendar 42
House of Representatives
11/16/2023
Committee Report: Inexpedient to Legislate HB172 11/08/2023 (Vote 19-0; Consent Calendar) House Calendar 49 P. 3
House of Representatives
1/3/2024
Inexpedient to Legislate: Motion Adopted Voice Vote 01/03/2024 House Journal 1 P. 34
House of Representatives
Status Information
Current Status
Introduced(1/3/2023)
Chamber
House of Representatives
Sine DiePrior Session
